Currently an exhibitor? Visit our Exhibitor Resource Center for up-to-date information.

Pri-Med Southwest 2013

Location: Houston, TX
Date: March 13-15, 2013

Meeting Overview

Venue:
George R. Brown Convention Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

 

As a primary care clinician, you are at the center of patient care.

Online registration for this event is now closed so that we may prepare for the program. Onsite registration opens Wednesday, March 13, 2013 at 7:00 AM.

Whether diagnosing and treating an acute illness or managing patients with complex medical needs, you ensure optimal patient outcomes. Managing multiple priorities—from daily patient care to office administration—makes it difficult to leave the office and recharge.

Pri-Med Conference & Exhibition offers low-cost continuing medical education in a flexible format. The CME conference schedule is designed to maximize your time out of the office, providing clinical updates on the disease states and patients you treat daily.

  • Women’s health
  • Pediatric and adolescent medicine
  • Cardiology for primary care clinicians
  • And many more topics for CME or CE credit

Earn up to 20.75 AMA PRA Category 1 Credits™.

For 2013, Harvard Medical School and Baylor College of Medicine have developed a curriculum of relevant lectures so you’re primed to deliver the best patient care.

Register for Pri-Med Southwest by: Your price*
November 9 $30
January 21 $40
February 15 $55
March 9 $75
On-site at Pri-Med Southwest $80
Save Meeting to Your Calendar

Have any ideas on how Pri-Med can improve your continuing medical education experience? Email us; we’d love to hear what you think.

*Price represents online registration. Registration by phone is an additional $10.

Primary Care Updates tracks are sponsored by pmiCME. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

Primary Care Updates activities are produced independently of and are not affiliated with Harvard Medical School or Baylor College of Medicine.

Pri-Med Southwest Full Conference Brochure

View the Pri-Med Southwest
Full Conference Brochure

 

Primary Care Updates*

March 13, 2013
A multi-track day of CME programs to supplement your education.

 

Current Clinical Issues in Primary Care

March 14–15, 2013
The core continuing medical education curriculum covering the latest topics in primary care medicine.

Harvard Medical School
Baylor College of Medicine
 

Educational Symposia

Independent, non-Harvard Medical School accredited CME sessions to expand your learning.


Non-CME Opportunities at Pri-Med Southwest
Be the first to know the latest innovations, technologies, and product research in the health care industry.

Exhibit Hall
Face-to-face conversations with industry professionals, helpful takeaways, and engaging floor activities.
Learn More » 

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.
Learn More »


Sessions & Syllabus

Following is a recap of the core educational elements from the conference sessions, to help you take what you learned and apply it to your interactions with patients.
Primary Care Updates, Wednesday, March 13, 2013 | Jump to:  Track 1  Track 2 
  Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Boehringer Ingelheim Pharmaceuticals, Inc., Forest Research Institute, a subsidiary of Forest Laboratories, Inc., and Ironwood Pharmaceuticals, Merck, Novo Nordisk Inc. and Vivus.
7:00 AM-7:50 AM
Registration & Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:15 AM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic

Learning Objectives:

  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
Robert Kushner, MD, Professor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Donna H. Ryan, MD (Read Bio), Professor Emeritus Pennington, Pennington Biomedical Research Center, Baton Rouge, LA
9:15 AM-9:30 AM
AM Break
9:30 AM-11:00 AM
Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes

Learning Objectives:

  1. Evaluate and apply current evidence regarding GLP-1 RA efficacy relative to other agents and across diabetes progression
  2. Evaluate and apply current evidence regarding safety of GLP-1 RAs, including recent data on specific label precautions (eg, thyroid cancer, pancreatitis, renal failure) and cardiovascular disease
  3. Evaluate and apply current evidence regarding tolerability and treatment satisfaction with GLP-1 RAs
  4. Evaluate and apply current evidence regarding nonglycemic effects of GLP-1 RAs (eg, effects on weight, blood pressure, lipid levels)
Lawrence Blonde, MD, FACP, FACE (Read Bio), Director, Ochsner Diabetes Clinical Research Unit, Department of Endocrinology, Diabetes and Metabolism, Associate Director, Internal Medicine Residency Program, Ochsner Medical Center, New Orleans, LA
Javier Morales, MD (Read Bio), St. Francis Hospital, Vice President, Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PC, Great Neck, NY
Jay Shubrook, DO, FACOFP, FAAFP, Associate Professor of Family Medicine, Director of Clinical Research, Department of Family Medicine, Director of Diabetes Fellowship, The Diabetes Institute, Ohio University Heritage College of Osteopathic Medicine, Athens, OH
11:00 AM-12:15 PM
Under Pressure: The Need to Expedite IBS Diagnosis and Treatment in Primary Care

Learning Objectives:

  1. Diagnose IBS based upon symptoms that may be shared with other functional gastrointestinal disorders or organic diseases
  2. Compare and contrast the efficacy and safety of available pharmacologic and non-pharmacologic treatment options for IBS
  3. Apply appropriate and comprehensive treatment strategies to enhance the care of patients with IBS
Lawrence R. Schiller, MD, FACS (Read Bio), Professor of Internal Medicine, Texas A&M Health Science Center, Dallas Campus, Dallas, TX, Program Director, Gastroenterology Fellowship, Baylor University Medical Center, Dallas, TX
Brian E. Lacy, MD, PhD (Read Bio), Director of the GI Motility Laboratory, Dartmouth-Hitchcock Medical Center, Lebanon, NH, Gastroenterology Fellowship, Gastroenterology and Hepatology, Lebanon, NH
12:15 PM-1:30 PM
Lunch
1:30 PM-3:00 PM
A New Frontier in Anticoagulation: Practical Issues and Considerations for Atrial Fibrillation Stroke Prevention in Primary Care

Learning Objectives:

  1. Apply the CHADS2 and HAS-BLED risk stratification tools in clinical practice to determine stroke and bleeding risk in patients with AF
  2. Incorporate current ACCP guideline recommendations and evidence-based approaches for stroke prevention in patients with AF while taking into account the benefit risk ratio of novel anticoagulants for each patient
  3. Recognize the importance of drug interactions, renal dysfunction, storage and handling in the application of novel anticoagulants in clinical practice
  4. Devise strategies to improve patient adherence and optimize outcomes in AF patients on novel anticoagulants undergoing surgery or experiencing bleeding
  5. Implement strategies for safe transitioning of AF patients to and from novel anticoagulants to improve patient outcomes
Kelley R. Branch, MD, MS, Assistant Professor, Attending Physician, University of Washington Medical Center, Seattle, WA
Bharat Kantharia, MD, FRCP, FAHA, FACC, FESC, FHRS, Professor of Medicine, Cardiology, The University of Texas Medical School, Houston, TX
3:00 PM-3:30 PM
PM Break
3:30 PM-4:45 PM
HPV Immunization: A Model for Cancer Prevention

Learning Objectives:

  1. Explain the epidemiology and burden of disease associated with HPV viruses
  2. Identify those HPV types most often associated with particular cancers and genital warts
  3. Discuss strategies to reduce the prevalence of these diseases
Kenneth A. Alexander, MD, PhD, Professor of Pediatrics, Chief, Section of Pediatric Infectious Diseases, University of Chicago Medical Center, Chicago, IL
Rachel Caskey, MD, MPP, Program Director, Med-Peds, Associate Section Chief, General Internal Medicine, Associate Section Chief, General Pediatrics, University of Illinois at Chicago, Chicago, IL
  Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible, in part, through collaborations with Eli Lilly and Company, Forest Laboratories, PamLab, sanofi-aventis U.S. Inc. and Vivus.
7:00 AM-7:50 AM
Registration & Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:15 AM
Depression: When Medical and Psychiatric Factors Collide

Learning Objectives:

  1. Identify the relationship between depression and medical factors (inflammatory, endocrine, metabolic)
  2. Select optimal treatments for patients with depression and comorbid medical conditions
  3. Assess the potential utility of biomarkers in the diagnosis and treatment of depression
Andrew J Cutler, MD (Read Bio), Courtesy Assistant Professor, Department of Psychiatry, University of Florida, Gainesville, FL, CEO & Chief Medical Officer, Florida Clinical Research Center, LLC, Maitland, FL
9:15 AM-9:30 AM
AM Break
9:30 AM-11:00 AM
Complementary Therapies to Improve Glucose Control in Type 2 Diabetes: Role of GLP-1 Receptor Agonists & Basal Insulin

Learning Objectives:

  1. Apply strategies to individualized therapy in the treatment of patients with type 2 diabetes
  2. Incorporate appropriate strategies for timely initiation, selection, titration, and self-management of basal insulin in patients with type 2 diabetes
  3. Describe the similarities and differences between individual GLP-1 receptor agonists
  4. Summarize the clinical rationale and evidence for combining GLP-1 receptor agonists with basal insulin so as to address various underlying pathophysiologic components of type 2 diabetes
Dace L Trence, MD, FACE, Associate Professor, Division of Metabolism, Endocrinology, and Nutrition, Director, Diabetes Care Center, University of Washington, Seattle, WA
Catherine Edwards, MD, FACE, Associate Professor and Program Director, Division of Endocrinology and Metabolism, University of Florida, Gainesville, FL
11:00 AM-12:15 PM
Clarifying the Confusion of COPD: Implementing Guidelines and Good Practice

Learning Objectives:

  1. Utilize current COPD guidelines including the use of spirometry for COPD diagnosis and monitoring for symptom control
  2. Evaluate the evidence for recommended standard and newer agents in improving COPD symptoms and decreasing exacerbations
Stephen I Rennard, MD (Read Bio), Larson Professor of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
Fernando J. Martinez, MD, MS, Professor, Department of Internal Medicine, Director, Pulmonary Diagnostic Services, University of Michigan, Ann Arbor, MI
12:15 PM-1:30 PM
Lunch
1:30 PM-3:00 PM
A Change in Diabetes Treatment Paradigms: Improving Glucose Control without Hypoglycemia and without Weight Gain

Learning Objectives:

  1. Assess current treatment goals for the comprehensive care of patients with type 2 diabetes
  2. Evaluate GLP-1 receptor agonists and DPP-4 inhibitors attributes relative to hypoglycemia and weight gain compared with other antiglycemic therapies
  3. Distinguish among available DPP-4 inhibitors
  4. Describe the role of the kidney in glucose homeostasis
Frank Lavernia, MD (Read Bio), Medical Founder and Director, North Broward Diabetes Center, Pompano Beach, FL
Richard Edwin Pratley, MD (Read Bio), Director, Florida Hospital Diabetes Institute, Senior Scientist, Florida Hospital Sanford|Burnham Translational Research Instit, Professor, Sanford-Burnham Medical Research Institute, Orlando, FL, Chair in Diabetes Research, Director, Florida Hospital Diabetes Institute, Samuel E. Crockett, FL
3:00 PM-3:30 PM
PM Break
3:30 PM-4:45 PM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic

Learning Objectives:

  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
Robert Kushner, MD, Professor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Donna H. Ryan, MD (Read Bio), Professor Emeritus Pennington, Pennington Biomedical Research Center, Baton Rouge, LA
Thursday, March 14, 2013
6:15 AM-7:45 AM Breakfast Symposia
6:15 AM-7:45 AM
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Mark D. Aronson, MACP, MD (Read Bio)
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 1: GI and Hepatology (ARS)

9:30 AM-10:10 AM Irritable Bowel Disease
Joseph Sellin, MD
10:10 AM-10:50 AM Managing GERD in 2013
Marcello Vela
10:50 AM-11:30 AM Gluten, Gluten Free Diet and Celiac Disease
Joseph Sellin, MD
Session 2: Primary Care Challenges

9:30 AM-10:10 AM Top Stories from the Medical Literature
Frank Domino, MD (Read Bio)
10:10 AM-10:50 AM Second Generation Antidepressants: Myths and Facts
Rayan Jurdi, MD
10:50 AM-11:30 AM Obesity Treatment
Jane Sillman, MD (Read Bio)
11:45 AM-1:15 PM Lunch Symposia
11:45 AM-1:15 PM
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 3: Cardiovascular Medicine (ARS)

1:30 PM-2:10 PM Atrial Fibrillation in Primary Care: An Update
Ihab Hamzeh, MD
2:10 PM-2:50 PM Congestive Heart Failure - Early Diagnosis and Treatment
Nasser Lakkis, MD (Read Bio)
2:50 PM-3:30 PM Choices in Anticoagulation
Lisa Weissmann, MD (Read Bio)
Session 5: Practice Innovations for Practical Use

1:30 PM-2:10 PM Understanding the Medicare Annual Wellness Visit
John Goodson, MD, FACP (Read Bio)
2:10 PM-2:50 PM The Phone: Clinicians’ Friend or Foe? Top 5 Advances
Harvey Katz, MD (Read Bio)
2:50 PM-3:30 PM Reducing Medical Errors in Ambulatory Care
Brigitta Mueller, MD
4:00 PM-6:00 PM Current Clinical Issues in Primary Care
Session 4: Women's Health (ARS)

4:00 PM-4:40 PM Cardiology Issues in Women
Gabriel Habib, MD (Read Bio)
4:40 PM-5:20 PM Primary Care for the Sexually Abused Woman
Ellen Long-Middleton, PhD, RN, FNP (Read Bio)
5:20 PM-6:00 PM Update on Contraception
Jane Sillman, MD (Read Bio)
Session 6: Pediatric & Adolescent Medicine I

4:00 PM-4:40 PM Hey, Was That a Seizure - Clinical Cases I
Mark Libenson, MD
4:40 PM-5:20 PM Prevention of Acquired Cardiovascular Disease in Children - New Guidelines
Douglas Moodie, MD
5:20 PM-6:00 PM Hey, Was That a Seizure - Clinical Cases II
Mark Libenson, MD
6:15 PM-7:45 PM Dinner Symposia
6:15 PM-7:45 PM
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
6:15 PM-8:45 PM Dinner Symposia
6:15 PM-8:45 PM
Accreditation: This activity has been accredited by Global Education Group. (Read Accreditation/Designation Statement)
Commercial Support: The CME activity is supported by an educational grant from Mallinckrodt, the Pharmaceuticals business of Covidien
Friday, March 15, 2013
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Mark Kline, MD
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 7: Live, On-Stage Orthopedic Demonstration

9:30 AM-10:30 AM Examination of the Shoulder
Frank Domino, MD (Read Bio)
10:30 AM-11:30 AM Examination of the Knee
Frank Domino, MD (Read Bio)
Session 8: Pediatrics II (ARS)

9:30 AM-10:10 AM Challenging Cases: What’s Your Diagnosis
Harvey Katz, MD (Read Bio)
10:10 AM-10:50 AM Seizures in Children - When to Refer to the Pediatric Neurologist
Angus Wilfong, MD
10:50 AM-11:30 AM Common Allergies in Pediatrics - What You Can Do in the Office
Celine Hanson, MD
11:45 AM-1:15 PM Lunch Symposia
11:45 AM-1:15 PM
James R. Gavin III, MD, PhD (Read Bio), Clinical Professor of Medicine, Emory University School of Medicine, Atlanta, GA, CEO & Chief Medical Officer, Healing Our Village, Inc, Atlanta, GA
Thomas Repas DO, FACP, FACE, CDE, FNLA, FACOI, Clinical Assistant Professor, Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Rapid City, SD
Davida F Kruger MSN, BC-ADM, APRN, Certified Nurse Practitioner, Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, MI, Division of Endocrinology, Diabetes and Bone Mineral Disorders, Detroit, MI
Commercial Support: The CME activity is supported by an educational grant from Novo Nordisk Inc.
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 9: Caring for the Older Patient (ARS)

1:30 PM-2:10 PM End of Life Care: Listening to the Patient
Ellen Long-Middleton, PhD, RN, FNP (Read Bio)
2:10 PM-2:50 PM Prevention of Falls in the Home and Community
John Culberson, MD
2:50 PM-3:30 PM Drug Treatment of Alzheimer’s
Jane Sillman, MD (Read Bio)
Session 11: Primary Care Potpourri I

1:30 PM-2:10 PM HIV Prevention: Antiretroviral Prophylaxis for Heterosexual Men and Women
Charlene Flash, MD
2:10 PM-2:50 PM Evaluation of Anemia
Lisa Weissmann, MD (Read Bio)
2:50 PM-3:30 PM Coffee in Health and Disease
Anita Kusnoor, MD
4:00 PM-6:00 PM Current Clinical Issues in Primary Care
Session 10: Pulmonary Medicine

4:00 PM-4:40 PM Upper Respiratory Infections
Mark Aronson, MACP, MD (Read Bio)
4:40 PM-5:20 PM Adult Asthma
Nicola Hanania, MD, FCCP, FRCP, FACP (Read Bio)
5:20 PM-6:00 PM Chronic Cough
Philip Alapat, MD, BS (Read Bio)
Session 12: Primary Care Potpourri II

4:00 PM-4:40 PM Viscosupplementation and Other Nonsurgical Treatment of Osteoarthritis of the Knee
Aravind Athiviraham, MD
4:40 PM-5:20 PM Fractures Involving the Tubular Bones of the Hand
Thomas Hunt, MD
5:20 PM-6:00 PM Ethical Considerations in Shared Decision Making*
Jennifer Blumenthal-Barby, PhD, MA (Read Bio)

Additional Opportunities

 
Product Theater
12
PM
1
PM
12:40 PM-1:25 PM
VASCEPA® A New Therapy for the Treatment of Severe Hypertriglyceridemia
Brought to you by: Amarin Pharma, Inc.

12:40 PM-1:25 PM
Alternative Fuel for the Alzheimer’s Brain: Helping to Improve Memory and Cognition
Brought to you by: Accera, Inc.

12:40 PM-1:25 PM
Inflammatory Back Pain Recognition and Diagnosis
Brought to you by: AbbVie

 
Product Theater
9
AM
9:00 AM-9:30 AM
A Clinical Review of LINZESS
Brought to you by: Forest Pharmaceuticals, Inc.

9:00 AM-9:30 AM
The Clinical Profile of Daliresp™ (roflumilast)
Brought to you by: Forest Pharmaceuticals, Inc.

11
AM
12
PM
11:35 AM-12:20 PM
Type 2 Diabetes Mellitus (T2DM): Pathophysiology, Therapeutic Needs, and Modulation of Glucose Homeostasis
Brought to you by: Janssen Pharmaceuticals, Inc.

11:35 AM-12:20 PM
Pneumococcal Disease in Adults 50+: A Prevention Option for Your Patients
Brought to you by: Pfizer Inc.

11:35 AM-12:20 PM
Expanding Therapeutic Options in Mild to Moderate Alzheimer’s Disease
Brought to you by: Novartis Pharmaceuticals

12
PM
1
PM
12:40 PM-1:25 PM
Allergic Rhinitis: Addressing the Unmet Needs
Brought to you by: Teva Respiratory

12:40 PM-1:25 PM
Reevaluating Overall Glycemic Control
Brought to you by: Novo Nordisk Inc.

 
Product Theater
9
AM
9:00 AM-9:30 AM
Pathophysiology and Management of Obesity: A Critical Disease
Brought to you by: Eisai, Inc.

9:00 AM-9:30 AM
Recognizing and Treating Moderate to Severe Alzheimer’s Disease in the Primary Care Setting
Brought to you by: Forest Pharmaceuticals, Inc.

11
AM
12
PM
11:35 AM-12:20 PM
Helicobacter pylori: Importance of Appropriate Testing and Management
Brought to you by: OAPI - Medical Device Division

11:35 AM-12:20 PM
Individualizing Treatment for Your Asthma and Exercise-Induced Bronchospasm Patients
Brought to you by: Teva Respiratory

11:35 AM-12:20 PM
XARELTO® to Reduce Thrombotic Risk
Brought to you by: Janssen Pharmaceuticals, Inc.

12
PM
1
PM
12:40 PM-1:25 PM
Clinical Insights to COPD: A lecture for Health Care Professionals
Brought to you by: Forest Pharmaceuticals, Inc.

12:40 PM-1:25 PM
Individualizing Care for Patients with Overactive Bladder
Brought to you by: Pfizer Inc.

Accreditation

Harvard Medical School 50x61

Current Clinical Issues in Primary Care

The educational program, Current Clinical Issues in Primary Care, is developed by the Course Development Committee of Harvard Medical School and Baylor College of Medicine. All decisions about the program content and faculty are made exclusively by the Course Development Committee. It is the mission of the Course Development Committee to develop, present, and promote an educational opportunity that is timely, relevant, free of commercial influence, and of the highest quality. To that end, we welcome your comments about how better to serve your needs.

Credits Type Accreditation Statement Designation Statement
14 AMA PRA Category 1 Credits™ The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Harvard Medical School designates this live educational activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
Pri-Med Institute 93x91

Primary Care Updates

This educational program is conceived and created in accordance with Accreditation Council for Continuing Medical Education (ACCME) Accreditation Criteria, the ACCME Standards for Commercial Support℠, and ACCME Policies. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME’s Advisory Boards and its expert review partner, Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.

Track 1

Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.375 hours of pharmacology).

Primary Care Updates

Track 2

Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.375 hours of pharmacology).

Keynote Speakers

Mark Aronson, MACP, MD (Read Bio)

Presenting on:

Mark Kline, MD

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Wednesday, March 13 11:00 AM–6:00 PM
Thursday, March 14 8:30 AM–2:30 PM
Friday, March 15 8:30 AM–2:00 PM

The Pri-Med Exhibit Hall is your chance to learn about and compare over 175 of the health care industry’s latest products, treatments, and technologies in one place.

Opening Night Reception
Pri-Med invites you to join us for the first-ever Opening Night Reception at Pri-Med Southwest. Network with your colleagues, faculty, and industry representatives on the Exhibit Hall Floor, starting at 5 pm*. As part of the festivities, there will be passed hors d'oeuvres, food stations, and an open bar.** Test your luck by participating in our passport program for an exciting chance to win an iPad or other medically relevant resources (details upon check-in).

*Conference badge required for entry.
** Food and beverage provided by DBC Pri-Med, LLC.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

Exhibit Floor Highlights

Presentation Theaters

Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Lunchtime workshops in the Presentation Theaters will focus on ways to boost revenue by adding ancillary products and services to your practice. Come and learn from some of the leading experts in the industry.


Amazing Charts

Visit the Amazing Charts booth #509 to learn about the #1‑rated EHR, and for a chance to win an iPad mini.

Presentation schedule:

March 13
12:15 PM Intro to EHR
12:45 PM Intro to EHR
3:00 PM Meaningful Use
5:00 PM Intro to ERH
5:30 PM Latest Features
March 14–15
8:45 AM Intro to EHR
11:30 AM Intro to EHR
NOON Meaningful Use
12:30 PM Intro to EHR
1:00 PM Latest Features

 

Exhibitor List

Company Name Booth Number
AbbVie 309
Aegis Sciences Corporation 604
Amarin Pharma, Inc. 125
American Express Open 515
AstraZeneca 330
Balance Back 601
Bio-Oil 133
Bristol-Myers Squibb Company 110
Cargill 535
Challenger Corporation 502
Concentra Primary Care 631
Critical Patient Care, Inc. 603
CryoSurgery, Inc 215
Dermalogix Partners Inc 304
Eisai, Inc. 230
Forest Pharmaceuticals, Inc. 108
HAE: Learn About It, Talk About It 518
Hemosure 634
Ideal Protein 325
Infinite Therapeutics 523
Janssen Pharmaceuticals, Inc. 301
Laclede Inc 419
Lippincott Williams & Wilkins 101
MD Anderson Cancer Center 508
Medical Device Division of Otsuka America Pharmaceutical, Inc. 217
Medtronic Inc 321
Mint Physician Staffing 200
MPR 418
Nova Medical Centers 326
Novo Nordisk Inc. 103
Schumacher Group 426
Sensa Products, LLC 403
Solutionreach 500
Take Care Health Systems 503
Televox Software, Inc. 209
The Gideons International 626
Vein Clinics of America 135
Visiting Physicians Association 112
Vitamix 621
World Institue of Surgical Excellence 401
Company Name Booth Number
Accera, Inc. 302
Alcat Worldwide 420
Amazing Charts 509
Army National Guard 424
Atherotech 223
Bionix Medical Technologies 205
Boston Scientific Corporation 630
Calmoseptine 314
Centers for Disease Control and Prevention 635
Clarity Genetics, Inc. DBA Clarity Women's Health 216
COPD Foundation 417
CryoProbe 308
Daiichi Sankyo, Inc 317
Doximity 211
Elsevier Medical Books 102
FRONTRUNNERS BOARD REVIEW 114
Hawaiian Moon 527
Houston Department of Health and Human Services 602
i-Lipo / Chromogenex 504
Intimina by Lelo 625
Kareo 203
Life Extension 411
Maico Diagnostics 227
Mederi Therapeutics, Inc 310
MediTouch EHR / HealthFusion 409
Micro Direct, Inc. 514
Mission Pharmacal Co 531
Neilmed Pharmaceuticals, Inc. 117
Novartis Pharmaceuticals Corporation 303
Pamlab, LLC 632
Sekisui Diagnostics 633
Shader Productions 627
Summit Doppler Systems 415
Takeda Pharmaceuticals U.S.A., Inc. 431
Teva Respiratory 516
Ultimate Creations 617
ViroPharma Incorporated 405
Vital Nutrients 416
Whitaker Medical 131
WynnPharm Inc. 100
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

George R. Brown Convention Center
1001 Avenida de las Americas
Houston, TX 77010-6032
(800) 427-4697

Important Parking Information
For the easiest access to Pri-Med Southwest please enter the Convention Center through Hall B. There are two parking lots closest to Hall B: underneath the Discovery Green and off of McKinney Street.

Official Travel Provider

Pri-Med’s official housing partner is onPeak (the new name of Travel Technology Group). onPeak is the only company endorsed by the Pri-Med event team to provide Pri-Med official housing and travel services. Please be aware of this if you are contacted by any other company and thank you for supporting the show by booking your hotel and travel through the official Pri-Med housing partner.

Online reservations for individuals or groups are simple and fast.

Stay at an Event Hotel for the lowest rate available. Airline and car rental reservations are also offered.